TOTIENT
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. It uses machine learning and immunoinformatics technology to pull critical insights from large, complex datasets, to quickly and accurately assemble the most potent antibody candidates. The unique applicability of the Totient platform allows the company to remain flexible and develop therapeutics for cancer, autoimmune disease, infections, and viruses. It was founded in 2017 and is based in Cambridge, Massachusetts.
TOTIENT
Industry:
Artificial Intelligence Biotechnology Life Science Machine Learning
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.totient.bio
Total Employee:
11+
Status:
Active
Contact:
(617) 221-8986
Email Addresses:
[email protected]
Total Funding:
10 M USD
Technology used in webpage:
Amazon Google Apps For Business Amazon Route 53 Amazon CloudFront
Similar Organizations
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
CytoVale
Categorized is a medical technology company that revolutionizes diagnostics using cell mechanics and machine learning.
Dyno Therapeutics
Dyno Therapeutics is a biotechnology company that uses artificial intelligence for gene therapy.
Kebotix
Kebotix is a high-tech materials discovery and production company that reinvent the discovery of new materials using AI.
Menten AI
Menten AI develops peptide and protein therapeutics using machine learning and quantum computing.
Protai
Protai is an AI-powered drug discovery startup.
ReviveMed
ReviveMed is a precision-medicine platform that leverages the data from small molecules or metabolites.
Current Employees Featured
Founder
Investors List
CerraCap Ventures
CerraCap Ventures investment in Venture Round - Totient
Tachyon Ventures
Tachyon Ventures investment in Seed Round - Totient
Viva Biotech
Viva Biotech investment in Seed Round - Totient
Andrew Izyumov
Andrew Izyumov investment in Seed Round - Totient
Sands Capital Ventures
Sands Capital Ventures investment in Seed Round - Totient
Kaitai Capital
Kaitai Capital investment in Seed Round - Totient
Jonathan Milner
Jonathan Milner investment in Seed Round - Totient
Helicase Venture
Helicase Venture investment in Seed Round - Totient
Tau Ventures
Tau Ventures investment in Seed Round - Totient
Mission BioCapital
Mission BioCapital investment in Seed Round - Totient
More informations about "Totient"
Totient - Crunchbase Company Profile & Funding
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody …See details»
Totient Company Profile 2024: Valuation, Investors, …
Totient General Information Description. Developer of antibodies intended for applications in cell therapies, ADCs, and bispecifics. The company uses machine learning, advanced immunoinformatics, and knowledge of the most recent …See details»
Absci Acquires Totient a Target Discovery Company | Absci
Jun 14, 2021 About Totient . Totient is enabling next generation cell therapies and other therapeutic modalities by building the largest library of human-derived antibodies to novel and …See details»
Totient, a Viva Biotech Portfolio Company, has been Acquired by …
SHANGHAI, June 15, 2021 /PRNewswire/ -- Viva Biotech (01873.HK) declared today that Totient, one of its portfolio companies, has been acquired by AbSci, a synthetic biology company …See details»
Totient - Viva BioInnovator
Totient. www.totient.bio. location. USA, Massachusetts, Cambridge. modality. Macro Molecule. Indications. Oncology. Infectious. Totient enables next generation cell therapies and other …See details»
Totient, a Viva Biotech Portfolio Company, is Acquired …
VANCOUVER, Wash., June 14, 2021 --- AbSci, the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, today announced the acquisition of Totient, a discovery company invested and …See details»
Totient, a Viva Biotech Portfolio Company, has been Acquired
About Totient. Totient is enabling next generation cell therapies and other therapeutic modalities by building the largest library of human-derived antibodies to novel and known tissue-specific …See details»
Totient - Devex
Totient is an AI-driven biotechnology company leveraging tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics.See details»
Totient | VentureRadar
Website: http://www.totient.bio/ Develops AI-driven drug discovery solutions using tertiary lymphoid structures to identify tissue-specific antigens and create high ...See details»
Totient Exits Stealth With $10M Seed Round - VC News Daily
Sep 10, 2020 Totient intends to advance a subset of their proprietary antibodies into the clinic while pursuing a broad and flexible partnering strategy for other candidates in parallel. About …See details»
Totient Company Profile - Office Locations, Competitors ... - Craft
Totient is an AI-driven biotechnology company specializing in cell therapies and therapeutic modalities. It develops an antibody discovery platform that reconstructs antibodies from …See details»
Totient - Part of Absci Overview | SignalHire Company Profile
Totient - Part of Absci is a private company that has been in the industry for 5 years. The company currently specializes in the Biotechnology, Biotechnology areas. ... Organization …See details»
Totient | Company | Mindmaps
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures. Investors. Brooks Hill Partners ... Investor Type: [email protected]. Funding Status: M&A. …See details»
Totient - Products, Competitors, Financials, Employees, …
Headquarters Location. 1 Alewife Center Suite 120. Cambridge, Massachusetts, 02140, United States. 617-221-8986See details»
Totient - Company Profile - Tracxn
Nov 13, 2024 Totient ranks 1,063rd among 3073 active competitors. 1115 of its competitors are funded while 654 have exited. Overall, Totient and its competitors have raised over $102B in …See details»
Totient - Overview, News & Similar companies | ZoomInfo.com
Jun 15, 2021 Totient contact info: Phone number: (617) 221-8986 Website: totient.bio What does Totient do? Totient is an AI-driven biotechnology company that leverages tertiary …See details»
Totient - Company info. interviews, news - BiopharmaTrend
Aug 18, 2022 Totient is an AI-driven biotechnology company leveraging tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity …See details»
Totient - Funding, Financials, Valuation & Investors - Crunchbase
Totient is an AI-driven biotechnology company that leverages tertiary lymphoid structures. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ... How much funding …See details»
Totient, Inc. Company Profile | Cambridge, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Totient, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
totient.bio: Revenue, Competitors, Alternatives - Growjo
Totient.bio 's estimated revenue per employee is $ 155,000Employee Data. totient.bio has 5 Employees. totient.bio; grew their employee count by 0%. last year. totient.bio 's People . …See details»